The Impact of ICH Q5A R2 on the Biopharmaceutical Market

BPI Contributor

February 14, 2024


Horst Rupach, Executive Director, Scientific and Portfolio Global Biologics, Charles River Laboratories, spoke with Brandy Fidler from Informa Connect Life Sciences about ICH Q5A R2. Rupach will be giving a presentation at BPI West in San Diego in March 2024.

Read the eBook and watch the pre-event interview here.

You May Also Like